quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:05:00·158d
PRRelease
Silo Pharma Inc. logo

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

SILO· Silo Pharma Inc.
Consumer Discretionary
Original source

Companies

  • SILO
    Silo Pharma Inc.
    Consumer Discretionary

Related

  • PR4d
    Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
  • SEC7d
    SEC Form 424B3 filed by Silo Pharma Inc.
  • SEC8d
    SEC Form EFFECT filed by Silo Pharma Inc.
  • SEC9d
    SEC Form 424B3 filed by Silo Pharma Inc.
  • SEC9d
    SEC Form POS AM filed by Silo Pharma Inc.
  • SEC10d
    SEC Form EFFECT filed by Silo Pharma Inc.
  • SEC13d
    SEC Form POS AM filed by Silo Pharma Inc.
  • PR17d
    Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022